publication venue for
- A patient survey evaluating COVID-19-induced changes in follow-up of patients with EBC: opportunities for enhanced evidence-based practice? 2023
- A pragmatic randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy for early breast cancer (REaCT-CHRONO Study) 2023
- Evolving strategies for the routine follow-up of patients with early breast cancer and the impact of COVID-19: a survey of healthcare providers 2023
- Clinical benefit according to biologic subtype and extent of disease: Who should not receive radiation? 2019
- Breast Irradiation after Conservative Surgery: Some-More-or None 2017
- PG 10.02 Evolving standards in breast cancer radiotherapy: who should receive locoregional RT? 2015
- Adjuvant therapy and thrombosis: How to avoid the problem? 2007
- S40 Adjuvant therapies and thrombosis: How to avoid the problem? 2007
- Regularly scheduled physical examinations and the detection of breast cancer recurrences. 69:274-280. 2023
- Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial. 68:189-193. 2023
- P021 A pragmatic randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy for early breast cancer (REaCT-CHRONO Study). 68:S24-S25. 2023
- P279 A patient survey evaluating COVID-19-induced changes in follow-up of patients with EBC: opportunities for enhanced evidence-based practice?. 68:S127-S127. 2023
- P291 Evolving strategies for the routine follow-up of patients with early breast cancer and the impact of COVID-19: a survey of healthcare providers. 68:S132-S132. 2023
- A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia. 58:42-49. 2021
- Neurocognitive outcomes following fetal exposure to chemotherapy for gestational breast cancer: A Canadian multi-center cohort study. 58:34-41. 2021
- Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations. 57:25-35. 2021
- Mepitel Film and Mepilex Lite for the prophylaxis and treatment of skin toxicities from breast radiation. 46:87-89. 2019
- Estimation of the benefit and harms of including clinical breast examination in an organized breast screening program. 43:105-112. 2019
- A retrospective review of phyllodes tumours of the breast: A single institution experience. 38:52-57. 2018
- Validation of the electronic version of the BREAST-Q in the army of women study. 33:44-49. 2017
- Barriers, beliefs and practice patterns for breast cancer reconstruction: A provincial survey. 32:60-65. 2017
- A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: A systematic review and meta-analysis. 31:157-166. 2017
- Relationship between anxiety disorders and domains of health related quality of life among Nigerians with breast cancer. 31:150-156. 2017
- Effects of a regional guideline for completion axillary lymph node dissection in women with breast cancer to reduce variation in surgical practice: A qualitative study of physicians' views. 29:126-131. 2016
- Supportive and palliative care for metastatic breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. 22:616-627. 2013
- Practice patterns and perceptions of margin status for breast conserving surgery for breast carcinoma: National Survey of Canadian General Surgeons. 21:730-734. 2012
- Local breast cancer recurrence after mastectomy and immediate breast reconstruction for invasive cancer: A meta-analysis. 21:230-236. 2012
- Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: A feasibility study. 20:96-98. 2011
- European oncologists' preferences for the management of breast cancer: case presentations and expert commentary. 17:S1-S12. 2008
- Adjuvant therapy and thrombosis: How to avoid the problem?. 16:169-174. 2007
- First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study. 13:219-226. 2004
- Doctors' participation in randomized trials of adjuvant systemic therapy in breast cancer: how does it relate to their recommendations for standard therapy in breast cancer?. 8:182-187. 1999